Immunotherapy Explained Part 2 – In Relation To Affimed. In part 3 here we explain and expand in the science of Immunotherapy and explain in part how $AFMD is differentiated, explain the $MRK Keytruda/AFM 13 trial plus a lot more.…
Tag: biopharma
Video Slide Presentation Immunotherapy + Affimed Explained Part 1
Immunotherapy Explained Part 1. Danny and I break down immunotherapy in this 3 part series. In part 1, we discuss an overview of the basic biology behind immunotherapy. Video is around 1 hour long. We talk about the various approaches…
Biotech and StockMarket Podcast May 31 2016
Biotech and StockMarket Podcast May 31 2016… $IONS $RLYP Gold, Oil + Macros $IONs discussed here on why we took call options. Danny explains the situation there and why it’s not as bad as the market is thinking. We also…
Updated: Immunotherapy-Oncology Webinar – Monday May 23rd @ 1 PM EST.
What is immunotherapy? Danny Cohen and myself will be doing a live webinar on Monday May 23rd at 1 pm EST, 10 am Western time. The webinar will be recorded and uploaded to this site afterwards. Topics explained and included…
Negative Interest Rates Next Up – Will Pump Markets But Destroy The Global Financial System
Once again, in the September Federal Reserve (FED) policy meeting, the FED did not raise the fed fund rate, leaving it at 0% to 0.25%. The stock market has had a huge run since the lows of 2009. At their…
Why This Small Cap Biotech Is Likely To Rally Soon
In small cap developmental biotech, we see a lot of creative financing, and when we understand how it works, we can profit from it. These types of biotech charts normally trade in a consistent ‘channel pattern.’ and when we spot…
Free Public Preview Video: Explanation on Current Market Situation Jan.29, 2014
Explanation on Current Market Situation Jan.29, 2014. $SPY reviewed later on in video. Mis-speak, I said “76 Million jobs” I later correct that to the proper “76 thousand jobs” I speak about potential head and shoulders in the charts, as…
BioPharma Catalyst And Investment Pick In Focus Synergy Pharma
Today at stockmatusow, we focus on a Bio-Pharmaceutical company with several near-term catalysts and give our thesis why we believe the company makes for a good long term speculative investment. Synergy Pharmaceuticals (SGYP) focuses on the development of drugs to…
Catalyst Trade Alert *UPDATED With Chart* – Re-Bought Progenics (PGNX) – Price Target Opinion = $6.50
Disclosure: I bought 25k shares of $PGNX @ $5.45 Biorunup’s Mark sold to go on vacation. Sheff remains bullish. we do as well. This is a pure catalyst trade which I talk about in my latest video. If Adcom for…
Sunshine Heart’s Pulse System Could Revolutionize How Heart Failure Is Treated
Recent developments in the medical device industry have paved the way for some strong achievements in many different sectors of the health care industry. With regards to heart failure, significant developments date back to the first implantable pacemaker successfully inserted…